Navigation Links
Sinovac Reports Unaudited Third Quarter 2011 Financial Results
Date:11/14/2011

BEIJING, Nov. 14, 2011 /PRNewswire-Asia/ -- Sinovac Biotech Ltd. (NASDAQ: SVA), a leading provider of biopharmaceutical products in China, announced today its unaudited third quarter financial results for the period ended September 30, 2011.

Financial Highlights

  • Sales in the third quarter increased 60.8% year-over-year to $15.4 million, compared to $9.6 million, and year-to-date sales increased 47.2% to $35.7 million.
  • Net loss attributable to stockholders in the third quarter was $2.1 million, or $0.04 per basic and diluted share. Year-to-date net loss attributable to stockholders was $3.6 million, or $0.07 per basic and diluted share.
  • Cash and cash equivalents and short-term investments with guaranteed income totaled $94.2 million at September 30, 2011, compared to $92.7 million at June 30, 2011 and $103.1 million at December 31, 2010.
  • Recent Business Highlights

  • In November 2011, Sinovac reported positive top-line results from its phase II clinical trial for its proprietary inactivated vaccine against human enterovirus 71 (EV71), which causes hand, foot and mouth disease (HFMD).  The preliminary phase II results for the EV71 vaccine showed good immunogenicity and a favorable safety profile with no vaccine-related serious adverse events and adverse reaction rate has no significant difference between the vaccinated group and control group.  
  • In October 2011, Sinovac was selected by the Beijing Centers for Disease Control and Prevention (Beijing CDC) as one of the four manufacturers to supply seasonal influenza vaccine to the citizens of Beijing for the fourth time in recent years.
  • In September 2011, Sinovac's inactivated animal rabies vaccine RabEnd received the final regulatory approval required to commence commercial sales when China's Ministry of Agriculture issued the production license.

  • '/>"/>
    SOURCE Sinovac Biotech Ltd.
    Copyright©2010 PR Newswire.
    All rights reserved

    Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20

    Related medicine technology :

    1. Sinovac Commences Vaccination on Volunteers for Phase II Clinical Trial on Pandemic Influenza H5N1 Vaccine
    2. Sinovac Provides Update in Pandemic Influenza Vaccines (H5N1) Phase II Clinical Trials
    3. Sinovac Initiates Phase II Volunteer Enrollment for Split Viron Pandemic Influenza (H5N1) Vaccine
    4. Sinovac Announces Plan to Launch Offering of Common Shares
    5. Sinovac Announces Recent Developments
    6. Sinovac Obtains Fifth H1N1 Vaccine Order from Chinese Central Government
    7. Sinovac Receives Purchase Order from Shanghai Government to Supply Hepatitis A Vaccine Healive(R)
    8. Sinovacs PANFLU.1 (H1N1) Regulatory Approval Expanded to Include Geriatric Population
    9. Sinovac Files Shelf Registration Statement
    10. Sinovac Named One of Chinas Top 10 Most Competitive Companies Listed Overseas in 2009
    11. Sinovacs CEO Weidong Yin Nominated for China Central Televisions Prestigious Economic Man-of-the-Year Award
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:7/28/2014)... Pharmacyclics, Inc. (the "Company") (Nasdaq: PCYC ... and audio webcast to discuss financial results for the second ... July 31, 2014 at 4:30 p.m. ET. ... July 31, 2014 Time: 4:30 PM ET Listen via Internet: ... A webcast replay will be available on the ...
    (Date:7/28/2014)... July 28, 2014  Dignity Health St. Mary,s ... the Get With The Guidelines®-Stroke Silver-Plus Quality Achievement ... by the American Heart Association/American Stroke Association for ... number four cause of death and a leading ... United States , according to the American ...
    (Date:7/28/2014)... Inc. (NASDAQ: ANTH ), today announced financial results ... 2014. Net loss for the three months ... million for the same period in 2013. The decrease in ... interest expense in the current period.  Net ... $15.2 million, compared with net loss of $15.9 million for ...
    Breaking Medicine Technology:Pharmacyclics Announces Date of Conference call to discuss Financial Results for Second Quarter of 2014 2Dignity Health St. Mary's Medical Center Honored with Quality Achievement Award for Stroke Care 2Dignity Health St. Mary's Medical Center Honored with Quality Achievement Award for Stroke Care 3Anthera Pharmaceuticals Reports 2014 Second Quarter Financial Results and Operational Update 2Anthera Pharmaceuticals Reports 2014 Second Quarter Financial Results and Operational Update 3Anthera Pharmaceuticals Reports 2014 Second Quarter Financial Results and Operational Update 4Anthera Pharmaceuticals Reports 2014 Second Quarter Financial Results and Operational Update 5Anthera Pharmaceuticals Reports 2014 Second Quarter Financial Results and Operational Update 6Anthera Pharmaceuticals Reports 2014 Second Quarter Financial Results and Operational Update 7
    (Date:7/28/2014)... 29, 2014 Treat skin to a true ... Beauty®. , Today and tomorrow only (while supplies last), take ... cleanser is ideal for two specific users: , 1) those ... and bacteria free, and , 2) aging skin to help ... Kathy Heshelow, founder of Sublime Beauty®. , Those with oily ...
    (Date:7/28/2014)... blood cell development have spread from Africa into nearly ... new study led by King,s College London. The international ... for the origin of changes in a key regulator ... haemoglobin is normally found in fetuses and infants, but ... to keep making it as adults experience milder symptoms ...
    (Date:7/28/2014)... July 29, 2014 A leading proposal ... Security disability trust fund by reallocating payroll taxes has ... poll by The Senior Citizens League (TSCL) . ... shifting revenues from the Social Security retirement trust fund ... fix the disability program’s financing. “TSCL believes this ‘band ...
    (Date:7/28/2014)... 29, 2014 NAPW honors ... County Hospital Center, as a 2014 Professional Woman of ... distinction for leadership in community health. As the largest, ... virtually every industry and profession, the National Association of ... with over 600,000 members and nearly 300 Local Chapters. ...
    (Date:7/28/2014)... have long known that they monopolize large amounts of ... cells are also characterized by a series of features ... ordered set. Researchers are calling this behavior "mesenchymal," and ... Meylan,s research team was able to demonstrate that the ... result from the same mechanism, at least in ...
    Breaking Medicine News(10 mins):Health News:Clear, Clean Skin With the New Salicylic Wash from Sublime Beauty®; Enlivens Skin, Unclogs Pores 2Health News:Study tracks worldwide spread of beneficial blood cell gene variant 2Health News:Study tracks worldwide spread of beneficial blood cell gene variant 3Health News:The Senior Citizens League Finds No Support Among Seniors for Likely Disability Trust Fund Fix 2Health News:The Senior Citizens League Finds No Support Among Seniors for Likely Disability Trust Fund Fix 3Health News:National Association of Professional Women Announces Pamela A. Schulters, Head Nurse at Kings County Hospital Center, a 2014 Professional Woman of the Year 2Health News:Cancer: Tumors absorb sugar for mobility 2
    ... incidents at the nation’s hospitals rose three percent over ... hospitals had a 40 percent lower rate of medical ... the largest annual study of patient-safety issued today by ... ,The HealthGrades study of 40.56 million Medicare hospitalization ...
    ... figure out the words' meaning for themselves, research by a ... an undergraduate student in the John Hopkins University and who ... by inference is more powerful for 3-year-olds than just being ... that is particularly exciting about the work Meredith is doing ...
    ... A homeopathic treatment for cancer is under trial at a ... it would pass muster in the next six months., ... homeopathic medicine have already begun in the United States and ... its efficacy," Dr Susanta K Banerjee, a professor of haematology ...
    ... the state children’s health insurance program (SCHIP), teens ... eliminated and more preventive care is received. This ... their health care providers about guns, smoking, drugs, ... their long-term health. ,"Adolescents have the ...
    ... For the first time ever, a team of Toronto ... tests //to screen high-risk pregnant mothers for placental damage. ... be reassured that their placenta is formed and functioning ... tests are done early enough, at 16 to 23 ...
    ... endogenous pain-inhibitory function and increases spontaneous pain in women//. ... in chronic pain, according to a study published in ... ,The study, conducted by Michael T. Smith, PhD, and ... females, who were studied polysomnographically for seven nights. On ...
    Cached Medicine News:Health News:Hospital Errors Rise 3 Percent -- HealthGrades Patient-safety Study 2Health News:Hospital Errors Rise 3 Percent -- HealthGrades Patient-safety Study 3Health News:Learning Words by Inference More Powerful for Toddlers 2Health News:Teens Get Needed Access to Care With State Health Insurance 2Health News:Teens Get Needed Access to Care With State Health Insurance 3Health News:New Placenta Screening for High-risk Pregnancies 2Health News:New Study in SLEEP Finds That Sleep Disturbance Increases Spontaneous Pain in Women 2
    Codman periosteal elevators, sharp, length 8" (203 mm), blade width 3/16" (5 mm)....
    Langenbeck periosteal elevators, wide, blade width 11/16" (17 mm), length 7 1/2" (191 mm)....
    Iowa University periosteal elevator, blade width 11/16" (17 mm), length 7 1/4" (184 mm)....
    Cushing-Hopkins periosteal elevator, Gutsch handle, blade width 7/16" (11 mm), length 7 5/8" (194 mm)....
    Medicine Products: